Incyte, Novartis to test repurposed cancer drug in COVID-19

The drugmakers, which are partnered on Incyte's therapy Jakafi, plan to quickly start Phase 3 trials in patients with inflammatory responses tied to COVID-19.

Incyte, Novartis to test repurposed cancer drug in COVID-19
The drugmakers, which are partnered on Incyte's therapy Jakafi, plan to quickly start Phase 3 trials in patients with inflammatory responses tied to COVID-19.